Published in Blood on November 15, 2000
Contribution of platelets to tumour metastasis. Nat Rev Cancer (2011) 4.16
Tumors as organs: complex tissues that interface with the entire organism. Dev Cell (2010) 3.98
Fibrinogen as a key regulator of inflammation in disease. Semin Immunopathol (2011) 2.14
Role of tissue factor in cancer. J Clin Oncol (2009) 1.91
Molecular mechanisms of metastasis in breast cancer--clinical applications. Nat Rev Clin Oncol (2010) 1.83
Peptides selected for binding to clotted plasma accumulate in tumor stroma and wounds. Proc Natl Acad Sci U S A (2006) 1.68
Platelet glycoprotein Ib alpha supports experimental lung metastasis. Proc Natl Acad Sci U S A (2007) 1.68
High D-dimer levels are associated with poor prognosis in cancer patients. Haematologica (2012) 1.62
Cross-talk of integrin alpha3beta1 and tissue factor in cell migration. Mol Biol Cell (2004) 1.57
Persistent signaling by dysregulated thrombin receptor trafficking promotes breast carcinoma cell invasion. Mol Cell Biol (2004) 1.50
Impact of venous thromboembolism and anticoagulation on cancer and cancer survival. J Clin Oncol (2009) 1.45
The initial hours of metastasis: the importance of cooperative host-tumor cell interactions during hematogenous dissemination. Cancer Discov (2012) 1.40
Disordered purinergic signaling inhibits pathological angiogenesis in cd39/Entpd1-null mice. Am J Pathol (2007) 1.32
Platelets: linking hemostasis and cancer. Arterioscler Thromb Vasc Biol (2010) 1.29
Amelioration of collagen-induced arthritis by thrombin inhibition. J Clin Invest (2001) 1.24
Plasma fibronectin promotes lung metastasis by contributions to fibrin clots and tumor cell invasion. Cancer Res (2010) 1.23
Hyperfibrinogenemia is associated with lymphatic as well as hematogenous metastasis and worse clinical outcome in T2 gastric cancer. BMC Cancer (2006) 1.18
Risk assessment, disease prevention and personalised treatments in breast cancer: is clinically qualified integrative approach in the horizon? EPMA J (2013) 1.17
The prognostic value of plasma fibrinogen levels in patients with endometrial cancer: a multi-centre trial. Br J Cancer (2010) 1.14
The impact of plasma Epstein-Barr virus DNA and fibrinogen on nasopharyngeal carcinoma prognosis: an observational study. Br J Cancer (2014) 1.12
FGF-2 binding to fibrin(ogen) is required for augmented angiogenesis. Blood (2005) 1.10
Anti-metastatic effect of a non-anticoagulant low-molecular-weight heparin versus the standard low-molecular-weight heparin, enoxaparin. Thromb Haemost (2006) 1.09
Circulating tumor cells in breast cancer: a tool whose time has come of age. BMC Med (2011) 1.07
Fibrinogen β-derived Bβ(15-42) peptide protects against kidney ischemia/reperfusion injury. Blood (2011) 1.07
Breast cancer proteomics reveals correlation between estrogen receptor status and differential phosphorylation of PGRMC1. Breast Cancer Res (2008) 1.07
Clinical and prognostic significance of preoperative plasma hyperfibrinogenemia in gallbladder cancer patients following surgical resection: a retrospective and in vitro study. BMC Cancer (2014) 1.02
Thrombomodulin is a determinant of metastasis through a mechanism linked to the thrombin binding domain but not the lectin-like domain. Blood (2011) 1.00
The hemostatic system and angiogenesis in malignancy. Neoplasia (2001) 0.99
High preoperative plasma fibrinogen is an independent predictor of distant metastasis and poor prognosis in renal cell carcinoma. Int J Clin Oncol (2012) 0.98
c-Jun N-Terminal Kinases Mediate a Wide Range of Targets in the Metastatic Cascade. Genes Cancer (2013) 0.98
Biomolecular characterization of CD44-fibrin(ogen) binding: distinct molecular requirements mediate binding of standard and variant isoforms of CD44 to immobilized fibrin(ogen). J Biol Chem (2008) 0.98
Single-molecule binding of CD44 to fibrin versus P-selectin predicts their distinct shear-dependent interactions in cancer. J Cell Sci (2011) 0.96
MicroRNA-223 delivered by platelet-derived microvesicles promotes lung cancer cell invasion via targeting tumor suppressor EPB41L3. Mol Cancer (2015) 0.96
Tissue factor and cancer. Thromb Res (2012) 0.95
Sequential binding of αVβ3 and ICAM-1 determines fibrin-mediated melanoma capture and stable adhesion to CD11b/CD18 on neutrophils. J Immunol (2010) 0.95
High plasma fibrinogen concentration and platelet count unfavorably impact survival in non-small cell lung cancer patients with brain metastases. Chin J Cancer (2013) 0.93
Preoperative plasma fibrinogen level is a useful predictor of adjacent organ involvement in patients with advanced gastric cancer. J Gastric Cancer (2012) 0.93
Quantitative estimation of Serum Fibrinogen Degradation Product levels in Oral Premalignant and Malignant lesions. J Int Oral Health (2013) 0.93
Prognostic significance of preoperative fibrinogen in patients with colon cancer. World J Gastroenterol (2014) 0.92
Targeting ECM Disrupts Cancer Progression. Front Oncol (2015) 0.92
Fibrinopeptides A and B release in the process of surface fibrin formation. Blood (2010) 0.92
Membrane-type-3 matrix metalloproteinase (MT3-MMP) functions as a matrix composition-dependent effector of melanoma cell invasion. PLoS One (2011) 0.91
Effect of preoperative hyperfibrinogenemia on recurrence of colorectal cancer without a systemic inflammatory response. World J Surg (2009) 0.90
The role of fibrinogen, fibrin and fibrin(ogen) degradation products (FDPs) in tumor progression. Contemp Oncol (Pozn) (2013) 0.89
The association of an elevated plasma fibrinogen level with cancer-specific and overall survival in prostate cancer patients. World J Urol (2014) 0.89
Contributions of thrombin targets to tissue factor-dependent metastasis in hyperthrombotic mice. J Thromb Haemost (2014) 0.88
Fibrinogen regulates the cytotoxicity of mycobacterial trehalose dimycolate but is not required for cell recruitment, cytokine response, or control of mycobacterial infection. Infect Immun (2009) 0.88
Cancer and venous thromboembolic disease: from molecular mechanisms to clinical management. Curr Oncol (2014) 0.88
Molecular imaging of fibrin in a breast cancer xenograft mouse model. Invest Radiol (2012) 0.88
Endogenous activated protein C is essential for immune-mediated cancer cell elimination from the circulation. Cancer Lett (2011) 0.87
Etk/Bmx regulates proteinase-activated-receptor1 (PAR1) in breast cancer invasion: signaling partners, hierarchy and physiological significance. PLoS One (2010) 0.86
Revisiting perioperative chemotherapy: the critical importance of targeting residual cancer prior to wound healing. BMC Cancer (2009) 0.86
Smoking, fibrinogen and cancer mortality. J Natl Med Assoc (2007) 0.86
Extracellular proteolysis in transgenic mouse models of breast cancer. J Mammary Gland Biol Neoplasia (2007) 0.86
Serum peptidomic biomarkers for pulmonary metastatic melanoma identified by means of a nanopore-based assay. Cancer Lett (2012) 0.85
Identification of tumor markers using two-dimensional electrophoresis in gastric carcinoma. World J Gastroenterol (2004) 0.85
Effect of anti-fibrinolytic therapy on experimental melanoma metastasis. Clin Exp Metastasis (2008) 0.85
Thrombin drives tumorigenesis in colitis-associated colon cancer. Cancer Res (2014) 0.84
Inhibition of tissue factor by ixolaris reduces primary tumor growth and experimental metastasis in a murine model of melanoma. Thromb Res (2012) 0.84
Targeted drug delivery to circulating tumor cells via platelet membrane-functionalized particles. Biomaterials (2015) 0.83
Specific extracellular matrix remodeling signature of colon hepatic metastases. PLoS One (2013) 0.83
Differential effects of anticoagulants on tumor development of mouse cancer cell lines B16, K1735 and CT26 in lung. Clin Exp Metastasis (2008) 0.82
Development of a green fluorescent protein metastatic-cancer chick-embryo drug-screen model. Clin Exp Metastasis (2004) 0.82
Colon Cancer Growth and Dissemination Relies upon Thrombin, Stromal PAR-1, and Fibrinogen. Cancer Res (2015) 0.82
Risk Factors for Postoperative Fibrinogen Deficiency after Surgical Removal of Intracranial Tumors. PLoS One (2015) 0.81
Discovery of an uncovered region in fibrin clots and its clinical significance. Sci Rep (2013) 0.81
Potential biomarkers for adult acute myeloid leukemia minimal residual disease assessment searched by serum peptidome profiling. Proteome Sci (2013) 0.81
Use of mouse models to study the role of tissue factor in tumor biology. Semin Thromb Hemost (2008) 0.81
Protease-activated receptors (PARs)-biology and role in cancer invasion and metastasis. Cancer Metastasis Rev (2015) 0.80
Clinical and Prognostic Significance of Preoperative Plasma Fibrinogen Levels in Patients with Operable Breast Cancer. PLoS One (2016) 0.80
Fibrin serves as a divalent ligand that regulates neutrophil-mediated melanoma cells adhesion to endothelium under shear conditions. Am J Physiol Cell Physiol (2012) 0.79
Impact of breast cancer stage, time from diagnosis and chemotherapy on plasma and cellular biomarkers of hypercoagulability. BMC Cancer (2014) 0.79
Plasma Fibronectin Promotes Tumor Cell Survival and Invasion through Regulation of Tie2. J Cancer (2013) 0.79
The effects of extracellular matrix proteins on neutrophil-endothelial interaction--a roadway to multiple therapeutic opportunities. Yale J Biol Med (2012) 0.79
Preoperative peripheral plasma fibrinogen level is an independent prognostic marker in penile cancer. Oncotarget (2016) 0.79
Novel circulating peptide biomarkers for esophageal squamous cell carcinoma revealed by a magnetic bead-based MALDI-TOFMS assay. Oncotarget (2016) 0.78
Neutrophils in the tumor microenvironment: trying to heal the wound that cannot heal. Immunol Rev (2016) 0.78
D-dimer: not just an indicator of venous thrombosis but a predictor of asymptomatic hematogenous metastasis in gastric cancer patients. PLoS One (2014) 0.78
Accuracy of D-dimer:fibrinogen ratio to diagnose pulmonary thromboembolism in patients admitted to intensive care units. Cardiovasc J Afr (2012) 0.78
Role of coagulation in the recruitment of colon adenocarcinoma cells to thrombus under shear. Am J Physiol Cell Physiol (2013) 0.78
Retracted Platelets and their role in cancer evolution and immune system. Transl Lung Cancer Res (2015) 0.78
Fibronectin Matrix Formation is a Prerequisite for Colonization of Kidney Tumor Cells in Fibrin. J Cancer (2015) 0.77
Elevated plasma fibrinogen level shows superior prognostic value than Epstein-Barr virus DNA load for stage IVA/B nasopharyngeal carcinoma patients in the intensity-modulated radiotherapy era. Oncotarget (2016) 0.77
Fibrinogen: a novel predictor of responsiveness in metastatic melanoma patients treated with bio-chemotherapy: IMI (italian melanoma inter-group) trial. J Transl Med (2003) 0.77
Influence of Stromal Components on Lung Cancer Carcinogenesis. J Carcinog Mutagen (2013) 0.77
Spontaneous metastasis in congenic mice with transgenic breast cancer is unaffected by plasminogen gene ablation. Clin Exp Metastasis (2012) 0.76
Blood clot formation does not affect metastasis formation or tumor growth in a murine model of breast cancer. PLoS One (2014) 0.76
Activation of carbonic anhydrase IX by alternatively spliced tissue factor under late-stage tumor conditions. Lab Invest (2016) 0.76
Relationships of coagulation factor XIII activity with cell-type and stage of non-small cell lung cancer. Yonsei Med J (2013) 0.76
siRNA-mediated silencing of integrin β3 expression inhibits the metastatic potential of B16 melanoma cells. Oncol Rep (2012) 0.76
Limiting prothrombin activation to meizothrombin is compatible with survival but significantly alters hemostasis in mice. Blood (2016) 0.76
Prognostic value of combined preoperative fibrinogen and neutrophil-lymphocyte ratio in patients with hepatocellular carcinoma after liver transplantation. Oncotarget (2016) 0.76
PDGF suppresses the sulfation of CD44v and potentiates CD44v-mediated binding of colon carcinoma cells to fibrin under flow. PLoS One (2012) 0.76
Proteome mapping of epidermal growth factor induced hepatocellular carcinomas identifies novel cell metabolism targets and mitogen activated protein kinase signalling events. BMC Genomics (2015) 0.75
Impact of D-Dimer for Prediction of Incident Occult Cancer in Patients with Unprovoked Venous Thromboembolism. PLoS One (2016) 0.75
Par genes: molecular probes to pathological assessment in breast cancer progression. Patholog Res Int (2011) 0.75
The comparison of plasma D-dimer levels in benign and malignant tumors of cervix, ovary and uterus. Int J Hematol Oncol Stem Cell Res (2015) 0.75
The Hemostasis Apparatus in Pancreatic Cancer and Its Importance beyond Thrombosis. Cancers (Basel) (2011) 0.75
Preoperative CA125 and fibrinogen in patients with endometrial cancer: a risk model for predicting lymphovascular space invasion. J Gynecol Oncol (2016) 0.75
Impaired wound healing in mice with a disrupted plasminogen gene. Nat Med (1996) 4.72
Complete hepatic regeneration after somatic deletion of an albumin-plasminogen activator transgene. Cell (1991) 3.31
Resolution of spontaneous bleeding events but failure of pregnancy in fibrinogen-deficient mice. Genes Dev (1995) 3.27
Plasminogen is required for efficient dissemination of B. burgdorferi in ticks and for enhancement of spirochetemia in mice. Cell (1997) 3.25
Replacement of diseased mouse liver by hepatic cell transplantation. Science (1994) 3.18
Plasminogen deficiency causes severe thrombosis but is compatible with development and reproduction. Genes Dev (1995) 2.81
Loss of fibrinogen rescues mice from the pleiotropic effects of plasminogen deficiency. Cell (1996) 2.72
Persistence of platelet thrombus formation in arterioles of mice lacking both von Willebrand factor and fibrinogen. J Clin Invest (2000) 2.68
Bleomycin-induced pulmonary fibrosis in fibrinogen-null mice. J Clin Invest (2000) 2.26
An extracellular proteolytic cascade promotes neuronal degeneration in the mouse hippocampus. J Neurosci (1997) 2.03
Fatal embryonic bleeding events in mice lacking tissue factor, the cell-associated initiator of blood coagulation. Proc Natl Acad Sci U S A (1996) 1.93
Neonatal bleeding in transgenic mice expressing urokinase-type plasminogen activator. Cell (1990) 1.83
Targeting of tumor cells by cell surface urokinase plasminogen activator-dependent anthrax toxin. J Biol Chem (2001) 1.73
Regulation of protein synthesis in mitogen-activated bovine lymphocytes. Analysis of actin-specific and total mRNA accumulation and utilization. J Biol Chem (1983) 1.73
Functional overlap between two classes of matrix-degrading proteases in wound healing. EMBO J (1999) 1.69
Urokinase-type plasminogen activator is effective in fibrin clearance in the absence of its receptor or tissue-type plasminogen activator. Proc Natl Acad Sci U S A (1996) 1.66
Fibrin and fibrinolysis in infection and host defense. J Thromb Haemost (2007) 1.66
Functional characterization of a natural retinoic acid responsive element. EMBO J (1991) 1.63
Reduced metastasis of Polyoma virus middle T antigen-induced mammary cancer in plasminogen-deficient mice. Oncogene (1998) 1.51
Lactational competence and involution of the mouse mammary gland require plasminogen. Development (2000) 1.48
Matriptase inhibition by hepatocyte growth factor activator inhibitor-1 is essential for placental development. Oncogene (2006) 1.47
Unliganded T3R, but not its oncogenic variant, v-erbA, suppresses RAR-dependent transactivation by titrating out RXR. EMBO J (1993) 1.45
The receptor for urokinase-type plasminogen activator is not essential for mouse development or fertility. J Biol Chem (1995) 1.45
Tissue plasminogen activator-mediated fibrinolysis protects against axonal degeneration and demyelination after sciatic nerve injury. J Cell Biol (2000) 1.43
Hepatocyte transplantation into diseased mouse liver. Kinetics of parenchymal repopulation and identification of the proliferative capacity of tetraploid and octaploid hepatocytes. Am J Pathol (2000) 1.39
Plasminogen deficiency leads to impaired remodeling after a toxic injury to the liver. Proc Natl Acad Sci U S A (1999) 1.38
Wound-healing defects in mice lacking fibrinogen. Blood (2001) 1.34
Impaired platelet aggregation and sustained bleeding in mice lacking the fibrinogen motif bound by integrin alpha IIb beta 3. EMBO J (1996) 1.33
Prothrombin deficiency results in embryonic and neonatal lethality in mice. Proc Natl Acad Sci U S A (1998) 1.32
Plasminogen activators direct reorganization of the liver lobule after acute injury. Am J Pathol (2001) 1.30
Neuronal death in the central nervous system demonstrates a non-fibrin substrate for plasmin. Proc Natl Acad Sci U S A (1997) 1.26
The plasminogen activation system enhances brain and heart invasion in murine relapsing fever borreliosis. J Clin Invest (1999) 1.22
The tissue plasminogen activator (tPA)/plasmin extracellular proteolytic system regulates seizure-induced hippocampal mossy fiber outgrowth through a proteoglycan substrate. J Cell Biol (2000) 1.21
Ligneous conjunctivitis in plasminogen-deficient mice. Blood (1998) 1.19
Crescentic glomerulonephritis is diminished in fibrinogen-deficient mice. Am J Physiol Renal Physiol (2001) 1.19
c-Met-induced epithelial carcinogenesis is initiated by the serine protease matriptase. Oncogene (2011) 1.18
Hepatocyte transplantation in a model of toxin-induced liver disease: variable therapeutic effect during replacement of damaged parenchyma by donor cells. Nat Med (2000) 1.17
Growth and dissemination of Lewis lung carcinoma in plasminogen-deficient mice. Blood (1997) 1.17
Factor XIII transglutaminase supports hematogenous tumor cell metastasis through a mechanism dependent on natural killer cell function. J Thromb Haemost (2008) 1.10
Induction and desensitization of plasminogen activator gene expression by tumor promoters. J Biol Chem (1985) 1.09
Biological effects of targeted inactivation of hepatocyte growth factor-like protein in mice. J Clin Invest (1998) 1.09
Healing of corneal epithelial defects in plasminogen- and fibrinogen-deficient mice. Invest Ophthalmol Vis Sci (1998) 1.06
Isolation of a cDNA clone encoding S-adenosylmethionine decarboxylase. Expression of the gene in mitogen-activated lymphocytes. J Biol Chem (1986) 1.03
Plasminogen deficiency leads to impaired lobular reorganization and matrix accumulation after chronic liver injury. Am J Pathol (2001) 1.03
Plasminogen deficiency accelerates vessel wall disease in mice predisposed to atherosclerosis. Proc Natl Acad Sci U S A (1997) 1.02
DNA rearrangement causes hepatocarcinogenesis in albumin-plasminogen activator transgenic mice. Proc Natl Acad Sci U S A (1992) 1.01
Role of the pleiotropic effects of plasminogen deficiency in infection experiments with plasminogen-deficient mice. Methods (2000) 1.01
Plasminogen deficiency results in poor clearance of non-fibrin matrix and persistent activation of hepatic stellate cells after an acute injury. J Hepatol (2001) 1.00
The Ron/STK receptor tyrosine kinase is essential for peri-implantation development in the mouse. J Clin Invest (1999) 0.97
Role of fibrinogen- and platelet-mediated hemostasis in mouse embryogenesis and reproduction. J Thromb Haemost (2004) 0.96
Suppression of Tumorigenicity-14, encoding matriptase, is a critical suppressor of colitis and colitis-associated colon carcinogenesis. Oncogene (2011) 0.95
The murine urokinase-type plasminogen activator gene. Biochemistry (1987) 0.95
Genetic manipulation of fibrinogen and fibrinolysis in mice. Ann N Y Acad Sci (2001) 0.93
A conserved TATA-less proximal promoter drives basal transcription from the urokinase-type plasminogen activator receptor gene. Blood (1995) 0.93
Autologous antibody response against the principal neutralizing domain of human immunodeficiency virus type 1 isolated from infected humans. J Virol (1993) 0.92
Plasminogen and wound healing. Nat Med (1996) 0.90
Plasminogen-independent initiation of the pro-urokinase activation cascade in vivo. Activation of pro-urokinase by glandular kallikrein (mGK-6) in plasminogen-deficient mice. Biochemistry (2000) 0.89
The murine urokinase-type plasminogen activator receptor gene. J Biol Chem (1994) 0.89
Neuronal death and blood-brain barrier breakdown after excitotoxic injury are independent processes. J Neurosci (1999) 0.88
Fibrinogen and tumor cell metastasis. Haemostasis (2001) 0.88
Fibrinogen deficiency is compatible with the development of atherosclerosis in mice. J Clin Invest (1998) 0.87
Persistent corneal haze after excimer laser photokeratectomy in plasminogen-deficient mice. Invest Ophthalmol Vis Sci (2000) 0.87
Fibrinogen deficiency reduces vascular accumulation of apolipoprotein(a) and development of atherosclerosis in apolipoprotein(a) transgenic mice. Proc Natl Acad Sci U S A (1998) 0.86
Plasminogen activator gene expression is induced by the src oncogene product and tumor promoters. J Biol Chem (1990) 0.85
Activation of single-chain urokinase-type plasminogen activator by platelet-associated plasminogen: a mechanism for stimulation of fibrinolysis by platelets. J Thromb Haemost (2010) 0.85
Cyclic AMP-dependent protein kinase controls basal gene activity and steroidogenesis in Y1 adrenal tumor cells. Biochemistry (1992) 0.85
The chicken urokinase-type plasminogen activator gene. J Biol Chem (1990) 0.85
Hemostatic factors in tumor biology. J Pediatr Hematol Oncol (2000) 0.83
The long terminal repeat of VL30 retrotransposons contains sequences that determine retinoic acid-induced transcription in cultured keratinocytes. J Biol Chem (1993) 0.82